The effect of a Persian medicine product on patients with severe persistent asthma

Comparison the effect of Persian medicine products (containing honey and flax seed) and placebo on Forced Expiratory Volume in First Second and wheezing intensity among patients with severe persistent asthma, A triple-blind randomized placebo-controlled trial

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20170112031893N5

Enrollment

Registered

2019-03-16

Start date

2019-03-21

Completion date

Unknown

Last updated

2019-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma. Severe persistent asthma

Interventions

Intervention 1: Intervention group: The group will use Persian medicine product (containing honey and flax seed), 40 gram for 3 months, every day. Intervention 2: Control group: The group will use pla

Eligibility

Sex/Gender

All

Age

12 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with severe persistent asthma over a year Age group 12-80

Exclusion criteria

Exclusion criteria: Kidney,liver,and heart failure based on the tests, history and physical exam High blood pressure more than 180 mm Hg Fever Pergnancy and lactation;

Design outcomes

Primary

Measure	Time frame
Forced Expiratory Volume in First Second. Timepoint: Before and after the intervention (end of month 3). Method of measurement: Spirometry testing.	—

Secondary

Measure	Time frame
Wheezing intensity determination. Timepoint: At the first of the study(before intervention) and 3 months after intervention. Method of measurement: History and physical exam with stethoscope.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHasan Adeli Nia

Ghoum University of Medical Sciences

huqom1394@yahoo.com+98 25 3886 0146

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026